|
US5716981A
(en)
*
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
|
CN1502331A
(zh)
|
1993-07-19 |
2004-06-09 |
Ѫ�ܼ���ҩ�﹫˾ |
抗血管生长组合物及使用方法
|
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5620013A
(en)
*
|
1994-10-21 |
1997-04-15 |
American Cyanamid Company |
Method for destroying residual lens epithelial cells
|
|
US5869079A
(en)
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US5904144A
(en)
*
|
1996-03-22 |
1999-05-18 |
Cytotherapeutics, Inc. |
Method for treating ophthalmic diseases
|
|
WO1997037680A1
(en)
*
|
1996-04-05 |
1997-10-16 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular complexes for drug delivery
|
|
US5935599A
(en)
*
|
1996-10-28 |
1999-08-10 |
The Board Of Trustees Of The University Of Illinois |
Polymer-associated liposomes for drug delivery and method of manufacturing the same
|
|
DE69827138T2
(de)
*
|
1997-08-11 |
2006-02-23 |
Allergan, Inc., Irvine |
Steriles Retinoid enthaltendes biodegradierbares Implantat mit verbesserter Biokompatibilität und Verfahren zu dessen Herstellung
|
|
US6007578A
(en)
*
|
1997-10-08 |
1999-12-28 |
Ras Holding Corp |
Scleral prosthesis for treatment of presbyopia and other eye disorders
|
|
US6991650B2
(en)
|
1997-10-08 |
2006-01-31 |
Refocus Ocular, Inc. |
Scleral expansion device having duck bill
|
|
RU2119780C1
(ru)
*
|
1997-10-28 |
1998-10-10 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
RU2120254C1
(ru)
*
|
1997-10-28 |
1998-10-20 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
AU760408B2
(en)
|
1998-04-27 |
2003-05-15 |
Surmodics, Inc. |
Bioactive agent release coating
|
|
WO2000000106A1
(en)
*
|
1998-06-29 |
2000-01-06 |
Rozakis George W |
Antioxidant intraocular lens
|
|
US6024719A
(en)
*
|
1998-07-06 |
2000-02-15 |
Morris; Robert E |
Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS)
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
|
FR2787991B1
(fr)
*
|
1998-12-31 |
2001-05-25 |
Medicale De Prec S M P Sa Soc |
Dispositif pour traiter la presbytie ou autre affection oculaire
|
|
EP1154691A4
(de)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
|
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
KR20020035476A
(ko)
|
1999-04-26 |
2002-05-11 |
지엠피 비젼 솔루션즈 인코포레이티드 |
측로 장치 및 녹내장 치료 방법
|
|
US6699210B2
(en)
*
|
1999-04-27 |
2004-03-02 |
The Arizona Board Of Regents |
Glaucoma shunt and a method of making and surgically implanting the same
|
|
JP4185282B2
(ja)
|
1999-06-07 |
2008-11-26 |
アールエーエス ホールディング コーポレイション |
老視および他の眼障害を治療するための、改善された強膜補てつ装具
|
|
US7008396B1
(en)
|
1999-09-03 |
2006-03-07 |
Restorvision, Inc. |
Ophthalmic device and method of manufacture and use
|
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
ES2240180T3
(es)
|
1999-10-21 |
2005-10-16 |
Alcon Inc. |
Administracion sub-tenon de medicamentos.
|
|
ATE414494T1
(de)
|
1999-10-21 |
2008-12-15 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
|
US6638239B1
(en)
*
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
|
US20050049578A1
(en)
*
|
2000-04-14 |
2005-03-03 |
Hosheng Tu |
Implantable ocular pump to reduce intraocular pressure
|
|
US20040111050A1
(en)
*
|
2000-04-14 |
2004-06-10 |
Gregory Smedley |
Implantable ocular pump to reduce intraocular pressure
|
|
US20050277864A1
(en)
*
|
2000-04-14 |
2005-12-15 |
David Haffner |
Injectable gel implant for glaucoma treatment
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
EP3167872B1
(de)
|
2000-07-05 |
2020-10-14 |
Allergan, Inc. |
Verfahren zur behandlung von entzündungsbedingten zuständen der augen
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
ATE404140T1
(de)
*
|
2000-08-30 |
2008-08-15 |
Univ Johns Hopkins |
Vorrichtung zur intraokularen wirkstoffverabreichung
|
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
|
AU2002248284A1
(en)
*
|
2000-11-01 |
2002-08-06 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
US6534693B2
(en)
*
|
2000-11-06 |
2003-03-18 |
Afmedica, Inc. |
Surgically implanted devices having reduced scar tissue formation
|
|
AU2002236495B2
(en)
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
|
CA2432438C
(en)
*
|
2001-01-09 |
2011-04-26 |
Microchips, Inc. |
Flexible microchip devices for ophthalmic and other applications
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
US6981958B1
(en)
*
|
2001-05-02 |
2006-01-03 |
Glaukos Corporation |
Implant with pressure sensor for glaucoma treatment
|
|
AU2002258754B2
(en)
|
2001-04-07 |
2006-08-17 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
|
WO2002089699A2
(en)
|
2001-05-03 |
2002-11-14 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
|
US20060241750A1
(en)
*
|
2001-05-22 |
2006-10-26 |
Ras Holding Corp |
Scleral expansion device having duck bill
|
|
JP4677538B2
(ja)
*
|
2001-06-12 |
2011-04-27 |
ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン |
眼内薬物送達のためのリザーバデバイス
|
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
US20050119742A1
(en)
*
|
2001-06-30 |
2005-06-02 |
Richter Paul W. |
Orbital implant
|
|
DE10133870A1
(de)
*
|
2001-07-12 |
2003-02-06 |
Chris P Lohmann |
Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
|
|
EP1385452B1
(de)
*
|
2001-07-23 |
2006-09-13 |
Alcon, Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
DE60217679T2
(de)
|
2001-07-23 |
2007-10-25 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
US8267995B2
(en)
*
|
2001-08-03 |
2012-09-18 |
David Castillejos |
Method and intra sclera implant for treatment of glaucoma and presbyopia
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
US7195774B2
(en)
*
|
2001-08-29 |
2007-03-27 |
Carvalho Ricardo Azevedo Ponte |
Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
IN2014DN10834A
(de)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
|
FR2833493B1
(fr)
*
|
2001-12-18 |
2005-09-23 |
Ioltechnologie Production |
Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
|
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
EP1482914B1
(de)
*
|
2002-03-11 |
2015-04-22 |
Novartis AG |
Implantierbare arzneimittelabgabevorrichtung fürs auge
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
US20040147870A1
(en)
*
|
2002-04-08 |
2004-07-29 |
Burns Thomas W. |
Glaucoma treatment kit
|
|
US20040024345A1
(en)
*
|
2002-04-19 |
2004-02-05 |
Morteza Gharib |
Glaucoma implant with valveless flow bias
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
CN1658836A
(zh)
*
|
2002-05-07 |
2005-08-24 |
控制传输系统公司 |
形成药物传递装置的方法
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
|
ES2277087T3
(es)
*
|
2002-07-09 |
2007-07-01 |
Aecc Enterprises Limited |
Metodo para representacion con imagenes el movimiento relativo de segmentos esqueleticos.
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
WO2004006890A1
(en)
*
|
2002-07-15 |
2004-01-22 |
Alcon, Inc. |
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
|
|
US20070027537A1
(en)
*
|
2002-08-02 |
2007-02-01 |
David Castillejos |
Method and intra-sclera implant for treatment of glaucoma and presbyopia
|
|
EP1539066B1
(de)
*
|
2002-09-17 |
2012-11-07 |
Iscience Surgical Corporation |
Gerät zur chirurgischen umleitung von wässrigen körperflüssigkeiten
|
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
|
AU2003272575B2
(en)
*
|
2002-09-18 |
2007-11-08 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US20050203542A1
(en)
*
|
2002-09-18 |
2005-09-15 |
Allergan, Inc. |
Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events
|
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
US20040111144A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Lawin Laurie R. |
Barriers for polymeric coatings
|
|
JP3814285B2
(ja)
*
|
2002-12-19 |
2006-08-23 |
ファイザー・インク |
眼疾患の治療に有用なプロテインキナーゼ阻害剤としての２−（１ｈ−インダゾール−６−イルアミノ）−ベンズアミド化合物
|
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
|
NZ540885A
(en)
*
|
2002-12-20 |
2009-02-28 |
Chakshu Res Inc |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
|
US9216106B2
(en)
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
|
ATE476960T1
(de)
*
|
2003-05-02 |
2010-08-15 |
Surmodics Inc |
System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
|
JP2007505932A
(ja)
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
|
US20050098470A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Davis Michael J. |
Kit for administration of a drug
|
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
PL1696822T3
(pl)
*
|
2003-11-13 |
2010-08-31 |
Psivida Inc |
Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
|
|
EP2168603A1
(de)
|
2003-11-14 |
2010-03-31 |
GenVec, Inc. |
Therapeutisches Programm zur Behandlung von Krebs
|
|
US7291125B2
(en)
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
WO2005056764A2
(en)
|
2003-12-05 |
2005-06-23 |
Compound Therapeutics, Inc. |
Inhibitors of type 2 vascular endothelial growth factor receptors
|
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
CN100548271C
(zh)
|
2004-01-20 |
2009-10-14 |
阿勒根公司 |
用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
|
|
US20050250788A1
(en)
*
|
2004-01-30 |
2005-11-10 |
Hosheng Tu |
Aqueous outflow enhancement with vasodilated aqueous cavity
|
|
CN1964748A
(zh)
|
2004-04-06 |
2007-05-16 |
苏莫迪克斯公司 |
用于生物活性剂的涂料组合物
|
|
JP2007532656A
(ja)
|
2004-04-12 |
2007-11-15 |
アメリカ合衆国 |
アデノウイルスベクターを用いて免疫応答を誘導するための方法
|
|
US7691381B2
(en)
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
US9549895B2
(en)
*
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20080058704A1
(en)
*
|
2004-04-29 |
2008-03-06 |
Michael Hee |
Apparatus and Method for Ocular Treatment
|
|
WO2005107664A2
(en)
*
|
2004-04-29 |
2005-11-17 |
Iscience Interventional Corporation |
Apparatus and method for surgical enhancement of aqueous humor drainage
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US7771742B2
(en)
*
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8512738B2
(en)
*
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
WO2006004795A2
(en)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
|
EP1765454B1
(de)
|
2004-07-02 |
2016-04-13 |
Mati Therapeutics Inc. |
Behandlungsmittelabgabevorrichtung für das auge
|
|
CA2573668A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Ophthalmic compositions and methods for treating ophthalmic conditions
|
|
ATE527281T1
(de)
|
2004-07-16 |
2011-10-15 |
Us Gov Health & Human Serv |
Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
EP2594259A1
(de)
|
2004-08-04 |
2013-05-22 |
Brookwood Pharmaceuticals, Inc. |
Verfahren zur Herstellung von Abgabevorrichtungen und damit erhaltene Vorrichtungen
|
|
US7722669B2
(en)
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
|
JP2008511336A
(ja)
*
|
2004-09-01 |
2008-04-17 |
アメリカ合衆国 |
免疫原性が増加したアデノウイルスベクターをインビボで用いる方法
|
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
EP3173072A1
(de)
*
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Einfach implantierbare wirkstoffzusammensetzungen mit verzögerter freisetzung
|
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
|
WO2006086750A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
US7699863B2
(en)
*
|
2005-03-01 |
2010-04-20 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US7785291B2
(en)
*
|
2005-03-01 |
2010-08-31 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
NZ561400A
(en)
*
|
2005-03-11 |
2010-02-26 |
Endo Pharmaceuticals Solutions |
Controlled release formulations of octreotide
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
JP2008533204A
(ja)
*
|
2005-03-21 |
2008-08-21 |
マクサイト， インコーポレイテッド |
病気又は症状の治療のためのドラッグ送達システム
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
|
WO2007009061A2
(en)
*
|
2005-07-13 |
2007-01-18 |
Anthrogenesis Corporation |
Ocular plug formed from placenta derived collagen biofabric
|
|
EA200800338A1
(ru)
*
|
2005-07-15 |
2008-08-29 |
Чакшу Рисерч Инк. |
Профилактика и лечение офтальмологических осложнений диабета
|
|
CA2616537A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
US7592330B2
(en)
*
|
2005-08-08 |
2009-09-22 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
|
AU2006284756B2
(en)
*
|
2005-08-31 |
2012-06-07 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
CA2850858A1
(en)
*
|
2005-09-16 |
2007-04-05 |
Allergan, Inc. |
Compositions and methods for the intraocular transport of therapeutic agents
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
WO2007047607A2
(en)
|
2005-10-18 |
2007-04-26 |
Allergan, Inc. |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
|
|
US9067047B2
(en)
*
|
2005-11-09 |
2015-06-30 |
The Invention Science Fund I, Llc |
Injectable controlled release fluid delivery system
|
|
CA2629163C
(en)
*
|
2005-11-10 |
2017-03-21 |
Genvec, Inc. |
Adenoviral vector-based foot-and-mouth disease vaccine
|
|
PL1968594T3
(pl)
|
2005-11-29 |
2011-03-31 |
Glaxosmithkline Llc |
Leczenie zaburzeń neowaskularyzacyjnych oka, takich jak zwyrodnienie plamki żółtej, rozszerzenie naczyń siatkówki w zespole Hippla i Lindaua, zapalenie błony naczyniowej oka i obrzęk plamki
|
|
EP1978892B1
(de)
*
|
2006-01-17 |
2017-11-15 |
Novartis Ag |
Behandlungsvorrichtung zur wirkstofffreisetzung
|
|
EP1979023B1
(de)
|
2006-01-17 |
2015-07-22 |
Transcend Medical, Inc. |
Glaukombehandlungsvorrichtung
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
US7964191B2
(en)
|
2006-02-02 |
2011-06-21 |
Allergan, Inc. |
Compositions and methods for the treatment of ophthalmic disease
|
|
US8492400B2
(en)
|
2006-02-09 |
2013-07-23 |
Santen Pharmaceutical Co., Ltd. |
Stable formulations, and methods of their preparation and use
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
US20080140057A1
(en)
*
|
2006-03-09 |
2008-06-12 |
Searete Llc, A Limited Liability Corporation Of State Of The Delaware |
Injectable controlled release fluid delivery system
|
|
EP2319558B1
(de)
*
|
2006-03-14 |
2014-05-21 |
University Of Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
|
CN101443004B
(zh)
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
|
EP2004172B1
(de)
|
2006-03-31 |
2019-03-13 |
Mati Therapeutics Inc. |
Wirkstofffreisetzungsstrukturen und zusammensetzungen für nasolacrimales system
|
|
US8676293B2
(en)
*
|
2006-04-13 |
2014-03-18 |
Aecc Enterprises Ltd. |
Devices, systems and methods for measuring and evaluating the motion and function of joint structures and associated muscles, determining suitability for orthopedic intervention, and evaluating efficacy of orthopedic intervention
|
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
|
US7871399B2
(en)
*
|
2006-05-17 |
2011-01-18 |
Alcon Research, Ltd. |
Disposable ophthalmic injection device
|
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
|
US9095411B2
(en)
|
2010-11-15 |
2015-08-04 |
Aquesys, Inc. |
Devices for deploying intraocular shunts
|
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
|
WO2008005873A2
(en)
|
2006-06-30 |
2008-01-10 |
Aquesys Inc. |
Methods, systems and apparatus for relieving pressure in an organ
|
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
|
EP3351211B1
(de)
|
2006-07-11 |
2023-09-06 |
Refocus Group, Inc. |
Sklerale prothese zur behandlung von altersweitsichtigkeit und anderen augenerkrankungen
|
|
US8911496B2
(en)
|
2006-07-11 |
2014-12-16 |
Refocus Group, Inc. |
Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
|
|
US20080097335A1
(en)
*
|
2006-08-04 |
2008-04-24 |
Allergan, Inc. |
Ocular implant delivery assemblies
|
|
EP2056833A2
(de)
|
2006-08-23 |
2009-05-13 |
Government of the United States of America, Represented by the Secretary, Department of Health and Human Services |
Harn- und thioharnsäurederivate für erkrankungen in verbindung mit oxidativem stress
|
|
US20100241046A1
(en)
*
|
2006-09-06 |
2010-09-23 |
Innfocus, Llc |
Apparatus, methods and devices for treatment of ocular disorders
|
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
|
JP5694664B2
(ja)
*
|
2006-09-29 |
2015-04-01 |
サーモディクス，インコーポレイティド |
生分解性眼用インプラント及び眼の病気を治療する方法
|
|
US20080091178A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Sunalp Murad A |
Device and method for medical records storage in the eye
|
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
|
BRPI0717644A2
(pt)
*
|
2006-10-16 |
2013-11-12 |
Alcon Res Ltd |
Método de operação de peça manual oftálmica com extremidade descartável.
|
|
ATE490752T1
(de)
*
|
2006-10-16 |
2010-12-15 |
Alcon Res Ltd |
Universelle aufladbare baugruppe mit eingeschränkter wiederverwendbarkeit für ein ophthalmisches handstück
|
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
|
US8586556B2
(en)
*
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
AU2007319383A1
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
WO2008063639A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
|
JP5537946B2
(ja)
|
2006-11-22 |
2014-07-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｉｇｆ−ｉｒを含むチロシンキナーゼ受容体に対する改変タンパク質に基づく標的治療薬
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
|
WO2008073576A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Alcon, Inc. |
Drug delivery device
|
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
US20090092574A1
(en)
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
|
US20080248060A1
(en)
*
|
2007-01-09 |
2008-10-09 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
JP4957258B2
(ja)
*
|
2007-01-15 |
2012-06-20 |
富士通株式会社 |
歩数計数装置および歩数計数方法
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
WO2008157614A2
(en)
*
|
2007-06-21 |
2008-12-24 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
|
EP2173289A4
(de)
|
2007-07-17 |
2010-11-24 |
Transcend Medical Inc |
Augenimplantat mit hydrogelausdehnungsfähigkeiten
|
|
US8968396B2
(en)
|
2007-07-23 |
2015-03-03 |
Powervision, Inc. |
Intraocular lens delivery systems and methods of use
|
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
|
ES2523681T3
(es)
*
|
2007-08-02 |
2014-11-28 |
Refocus Group, Inc. |
Prótesis escleral que tiene varillas transversales para tratar la presbicia y otros trastornos del ojo
|
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
|
US9011361B2
(en)
|
2007-09-07 |
2015-04-21 |
Mati Therapeutics Inc. |
Lacrimal implant detection
|
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
|
US20090099481A1
(en)
|
2007-10-10 |
2009-04-16 |
Adam Deitz |
Devices, Systems and Methods for Measuring and Evaluating the Motion and Function of Joints and Associated Muscles
|
|
US9849027B2
(en)
|
2007-11-08 |
2017-12-26 |
Alimera Sciences, Inc. |
Ocular implantation device
|
|
CA2709712C
(en)
|
2007-12-20 |
2016-05-10 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
EP2666510B1
(de)
|
2007-12-20 |
2017-10-18 |
University Of Southern California |
Vorrichtung zur kontrollierten Abgabe von Therapeutika
|
|
US20090162417A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Cook Incorporated |
Drug eluting ocular conformer
|
|
EP2727616B1
(de)
|
2008-01-03 |
2017-04-26 |
University Of Southern California |
Implantierbare Wirkstofffreisetzungsvorrichtungen sowie Geräte und Verfahren zum Auffüllen der Vorrichtungen
|
|
US8602959B1
(en)
*
|
2010-05-21 |
2013-12-10 |
Robert Park |
Methods and devices for delivery of radiation to the posterior portion of the eye
|
|
JP2011517314A
(ja)
|
2008-02-14 |
2011-06-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
US20090227938A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Insitu Therapeutics, Inc. |
Wound Closure Devices, Methods of Use, and Kits
|
|
US9333297B2
(en)
|
2008-05-08 |
2016-05-10 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
EP2323716B1
(de)
|
2008-05-08 |
2015-03-04 |
MiniPumps, LLC |
Arzneiabgabepumpen
|
|
CN102202719B
(zh)
*
|
2008-05-08 |
2014-11-26 |
迷你泵有限责任公司 |
可植入泵和用于可植入泵的插管
|
|
WO2009137777A2
(en)
*
|
2008-05-08 |
2009-11-12 |
Replenish Pumps, Llc |
Implantable drug-delivery devices, and apparatus and methods for filling the devices
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
JP5591226B2
(ja)
|
2008-05-12 |
2014-09-17 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
眼内薬物送達装置および関連する方法
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
PE20091931A1
(es)
|
2008-05-22 |
2009-12-31 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
|
WO2009158524A2
(en)
|
2008-06-25 |
2009-12-30 |
Transcend Medical, Inc. |
Ocular implant with shape change capabilities
|
|
ES2518418T3
(es)
|
2008-08-01 |
2014-11-05 |
Eye Therapies Llc |
Composiciones de vasoconstricción y métodos de uso
|
|
US12246013B2
(en)
|
2008-08-01 |
2025-03-11 |
Eye Therapies Llc |
Vasoconstriction compositions and methods of use
|
|
US20110190323A1
(en)
|
2008-08-28 |
2011-08-04 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses thereof
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
US9943402B2
(en)
|
2008-11-20 |
2018-04-17 |
Insight Innovations, Llc |
Micropatterned intraocular implant
|
|
US8551167B2
(en)
|
2008-11-20 |
2013-10-08 |
Insight Innovations, Llc |
Intraocular implant cell migration inhibition system
|
|
US20120232649A1
(en)
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
|
AU2009318158B2
(en)
*
|
2008-11-20 |
2016-01-14 |
Insight Innovations, Llc |
Biocompatible biodegradable intraocular implant system
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
US20100191177A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Iscience Interventional Corporation |
Device for aspirating fluids
|
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
|
EP2548538B1
(de)
|
2009-01-28 |
2020-04-01 |
Alcon Inc. |
Implantationssysteme für augenimplantate mit steifheitseigenschaften
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CA3045436C
(en)
|
2009-01-29 |
2025-10-07 |
Forsight Vision4, Inc. |
ADMINISTRATION OF A MEDICATION IN THE POSTERIOR SEGMENT
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
|
US8372036B2
(en)
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
|
USD629503S1
(en)
|
2009-05-08 |
2010-12-21 |
Sean Caffey |
Implantable drug-delivery pump
|
|
JP5937004B2
(ja)
|
2009-05-18 |
2016-06-22 |
ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ |
薬剤溶出眼内インプラント
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
AU2010256558B2
(en)
|
2009-06-03 |
2013-10-03 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
CA2803059A1
(en)
|
2009-06-19 |
2010-12-23 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
|
KR101697388B1
(ko)
|
2009-08-18 |
2017-01-17 |
미니펌프스, 엘엘씨 |
적응 제어기를 갖춘 전해 약품 운반 펌프
|
|
US9605844B2
(en)
*
|
2009-09-01 |
2017-03-28 |
Cree, Inc. |
Lighting device with heat dissipation elements
|
|
US9138163B2
(en)
|
2009-09-25 |
2015-09-22 |
Ortho Kinematics, Inc. |
Systems and devices for an integrated imaging system with real-time feedback loop and methods therefor
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
US20120219583A1
(en)
|
2009-10-16 |
2012-08-30 |
Los Alamos National Security, Llc |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
|
ES2603057T3
(es)
*
|
2009-10-30 |
2017-02-23 |
Aton Pharma, Inc. |
Dispositivos de administración ocular de fármacos
|
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
|
EP3421030A1
(de)
|
2009-11-09 |
2019-01-02 |
Allergan, Inc. |
Zusammensetzungen und verfahren zur stimulation des haarwuchses
|
|
EP2498778A1
(de)
|
2009-11-13 |
2012-09-19 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Diazeniumdiolatverbindungen, pharmazeutische zusammensetzungen und verfahren zur behandlung von krebs
|
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
WO2011106435A2
(en)
|
2010-02-23 |
2011-09-01 |
Powervision, Inc. |
Fluid for accommodating intraocular lenses
|
|
WO2011106697A1
(en)
|
2010-02-25 |
2011-09-01 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
EP2547362B1
(de)
|
2010-03-17 |
2021-08-25 |
Cornell University |
Unterbrochener impfstoff auf adenovirusbasis gegen drogenmissbrauch
|
|
EP2547660B1
(de)
|
2010-03-19 |
2015-01-07 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Nitroxyl (hno)-freisetzende verbindungen und ihre verwendung zur behandlung von erkrankungen
|
|
WO2011133964A2
(en)
|
2010-04-23 |
2011-10-27 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
|
EP2383286A1
(de)
|
2010-04-30 |
2011-11-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen
|
|
JP6022441B2
(ja)
|
2010-04-30 |
2016-11-09 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
抗Ｃ５ａ抗体およびその抗体の使用のための方法
|
|
JP2013526572A
(ja)
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
|
US9562089B2
(en)
|
2010-05-26 |
2017-02-07 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
|
EP2627292B1
(de)
*
|
2010-10-15 |
2018-10-10 |
Clearside Biomedical, Inc. |
Vorrichtung für okularen zugang
|
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
|
US20160256317A1
(en)
|
2010-11-15 |
2016-09-08 |
Aquesys, Inc. |
Methods for implanting intraocular shunts
|
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
AU2011344107A1
(en)
|
2010-12-13 |
2013-06-27 |
Ortho Kinematics, Inc. |
Methods, systems and devices for clinical data reporting and surgical navigation
|
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
|
WO2012114138A1
(fr)
*
|
2011-02-21 |
2012-08-30 |
Cerebel-Invest Sa |
Implants biodégradables pour la libération contrôlée sous-conjonctivale d'une molécule active
|
|
US10842849B2
(en)
|
2011-02-28 |
2020-11-24 |
The Schepens Eye Research Institute, Inc. |
Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
|
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
WO2012131583A2
(en)
*
|
2011-03-27 |
2012-10-04 |
Microsert Ltd. |
Miniature implanted drug delivery devices and inserter systems for introducing such devices
|
|
US9012647B2
(en)
|
2011-04-07 |
2015-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
|
|
US8889672B2
(en)
|
2011-04-29 |
2014-11-18 |
The Regents Of The University Of Michigan |
Compounds, formulations, and methods of protein kinase C inhibition
|
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
|
EP4083074A1
(de)
|
2011-06-02 |
2022-11-02 |
Massachusetts Institute Of Technology |
Modifizierte alginate für zellverkapselung und zelltherapie
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US20150005254A1
(en)
|
2011-06-27 |
2015-01-01 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
|
EP4193907B1
(de)
|
2011-09-13 |
2026-04-15 |
Glaukos Corporation |
Intraokularer physiologischer sensor
|
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
|
RU2014118642A
(ru)
|
2011-10-12 |
2015-11-20 |
Асцендис Фарма Офтальмолоджи Дивижн А/С |
Предотвращение и лечение глазных нарушений
|
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
JP6254090B2
(ja)
|
2011-10-21 |
2017-12-27 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
軸索再生および神経機能を促進するための方法および組成物
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
|
US8852136B2
(en)
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
|
US9241829B2
(en)
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US20150038557A1
(en)
|
2012-02-24 |
2015-02-05 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treatment of retinal degenerative diseases
|
|
US10093947B2
(en)
|
2012-02-28 |
2018-10-09 |
Cornell University |
AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
|
US10004811B2
(en)
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
|
WO2013180967A1
(en)
|
2012-05-29 |
2013-12-05 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
MX351261B
(es)
|
2012-06-01 |
2017-10-06 |
Surmodics Inc |
Aparato y método para recubrir catéteres con globo.
|
|
CN104334123B
(zh)
|
2012-06-07 |
2019-02-12 |
意比图密医疗有限公司 |
膨胀装置
|
|
ES2633185T3
(es)
|
2012-09-17 |
2017-09-19 |
Novartis Ag |
Dispositivos de implante ocular expansibles
|
|
WO2014052518A1
(en)
|
2012-09-27 |
2014-04-03 |
Allergan, Inc. |
Biodegradable drug delivery systems for the sustained release of proteins
|
|
EP2911623B1
(de)
|
2012-10-26 |
2019-08-14 |
Forsight Vision5, Inc. |
Ophthalmisches system für die verzögerte freisetzung von arzneimitteln ins auge
|
|
KR102467714B1
(ko)
|
2012-11-08 |
2022-11-16 |
클리어사이드 바이오메디컬, 인코포레이드 |
인간 대상체에서 안구 질병을 치료하기 위한 방법 및 장치
|
|
WO2014078288A1
(en)
|
2012-11-14 |
2014-05-22 |
Transcend Medical, Inc. |
Flow promoting ocular implant
|
|
EP3929206A1
(de)
|
2012-11-15 |
2021-12-29 |
Apellis Pharmaceuticals, Inc. |
Langwirkende compstatin-analoga sowie verwandte zusammensetzungen und verfahren
|
|
WO2014093270A1
(en)
|
2012-12-10 |
2014-06-19 |
Virginia Commonwealth University |
Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7)
|
|
NZ710444A
(en)
|
2013-02-11 |
2020-08-28 |
Univ California |
Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
|
|
CA2901280A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
|
MY199344A
(en)
|
2013-02-18 |
2023-10-24 |
Vegenics Pty Ltd |
Ligand binding molecules and uses thereof
|
|
US9125723B2
(en)
|
2013-02-19 |
2015-09-08 |
Aquesys, Inc. |
Adjustable glaucoma implant
|
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
|
JP6511430B2
(ja)
|
2013-03-11 |
2019-05-15 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
がんの治療のための化合物および組成物
|
|
AU2014249045A1
(en)
|
2013-03-11 |
2015-10-29 |
University Of Florida Research Foundation, Inc. |
Delivery of CARD protein as therapy for occular inflammation
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
US10308687B2
(en)
|
2013-03-15 |
2019-06-04 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
EP3785668A1
(de)
|
2013-03-15 |
2021-03-03 |
Alcon Inc. |
Aufbewahrungs- und ladevorrichtung für intraokularlinsen und verfahren zur verwendung
|
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
|
AU2014259694B2
(en)
|
2013-05-03 |
2018-11-08 |
Clearside Biomedical, Inc. |
Apparatus and methods for ocular injection
|
|
US10274503B2
(en)
|
2013-05-08 |
2019-04-30 |
Vegenics Pty Limited |
Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
|
|
WO2015035190A1
(en)
|
2013-09-05 |
2015-03-12 |
Cornell University |
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
|
|
SG10201800978UA
(en)
|
2013-10-31 |
2018-03-28 |
Allergan Inc |
Prostamide-containing intraocular implants and methods of use thereof
|
|
US10087224B2
(en)
|
2013-11-01 |
2018-10-02 |
Cornell University |
Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
MA39111A1
(fr)
|
2013-11-14 |
2017-04-28 |
Eyed Pharma |
Dispositif oculaire
|
|
US9585790B2
(en)
|
2013-11-14 |
2017-03-07 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
BR112016012615B1
(pt)
|
2013-12-05 |
2023-02-07 |
Epitomee Medical Ltd |
Sistemas, e kit
|
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
|
CA2934819A1
(en)
|
2013-12-24 |
2015-07-02 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
|
EP3089748A4
(de)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Behandlung von neovaskularisierung im auge
|
|
WO2015112739A1
(en)
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
|
CA2939219C
(en)
|
2014-02-11 |
2023-02-28 |
Mitokinin Llc |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
CA2948728A1
(en)
|
2014-03-10 |
2015-09-17 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
|
|
EP3126495A1
(de)
|
2014-04-02 |
2017-02-08 |
Editas Medicine, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit crispr/cas zur behandlung eines primären offenwinkelglaukoms
|
|
US20150342875A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
RU2695563C2
(ru)
|
2014-07-15 |
2019-07-24 |
Форсайт Вижн4, Инк. |
Способ и устройство для доставки глазного имплантата
|
|
CA2956075C
(en)
|
2014-08-01 |
2020-03-10 |
Massachusetts Institute Of Technology |
Modified alginates for anti-fibrotic materials and applications
|
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
JP7037360B2
(ja)
|
2014-11-10 |
2022-03-16 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
拡張可能な薬物送達デバイス
|
|
FR3028410A1
(fr)
|
2014-11-18 |
2016-05-20 |
Pierre Coulon |
Implant capsulaire multifonctionnel
|
|
US10293059B2
(en)
|
2015-04-09 |
2019-05-21 |
Cornell University |
Gene therapy to prevent reactions to allergens
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
WO2016182932A1
(en)
|
2015-05-08 |
2016-11-17 |
President And Fellows Of Harvard College |
Cortistatin analogues, syntheses, and uses thereof
|
|
WO2016183297A1
(en)
|
2015-05-12 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
|
KR20180014051A
(ko)
|
2015-05-28 |
2018-02-07 |
코넬 유니버시티 |
혈관 부종 치료제로서의 아데노-관련 바이러스 매개 c1e1의 전달
|
|
JP6916742B2
(ja)
|
2015-06-03 |
2021-08-11 |
アクエシス， インコーポレイテッド |
Ａｂ ｅｘｔｅｒｎｏ（眼外から眼内へ）の眼内シャント配置
|
|
US20160354161A1
(en)
|
2015-06-05 |
2016-12-08 |
Ortho Kinematics, Inc. |
Methods for data processing for intra-operative navigation systems
|
|
ES2962463T3
(es)
|
2015-06-10 |
2024-03-19 |
Alcon Inc |
Materiales y componentes de lentes intraoculares
|
|
WO2017004411A1
(en)
|
2015-07-01 |
2017-01-05 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
CA3015702A1
(en)
|
2015-09-02 |
2017-03-09 |
Trevena, Inc. |
6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
CA3287719A1
(en)
|
2015-10-07 |
2026-03-02 |
Apellis Pharmaceuticals, Inc. |
Use of long-acting compstatin analog for treating a complement-mediated disorder
|
|
JP7408284B2
(ja)
|
2015-10-30 |
2024-01-05 |
エディタス・メディシン、インコーポレイテッド |
単純ヘルペスウイルスを治療するためのｃｒｉｓｐｒ／ｃａｓ関連方法及び組成物
|
|
ES2978718T3
(es)
|
2015-11-01 |
2024-09-18 |
Massachusetts Inst Technology |
Alginatos modificados para materiales antifibróticos y aplicaciones
|
|
WO2017075630A1
(en)
*
|
2015-11-01 |
2017-05-04 |
Massachusetts Institute Of Technology |
Materials with improved properties
|
|
WO2017082946A1
(en)
|
2015-11-13 |
2017-05-18 |
University Of Utah Research Foundation |
Combinatorial gene construct and non-viral delivery for anti-obesity
|
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
|
WO2017139375A1
(en)
|
2016-02-10 |
2017-08-17 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
|
US11583528B2
(en)
|
2016-02-17 |
2023-02-21 |
Children's Medical Center Corporation |
FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
|
|
US10883108B2
(en)
|
2016-03-31 |
2021-01-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
BR112018070383A2
(pt)
|
2016-04-05 |
2019-02-05 |
Forsight Vision4 Inc |
dispositivos para aplicação de fármaco oculares implantáveis
|
|
US11318043B2
(en)
|
2016-04-20 |
2022-05-03 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
|
WO2017192565A1
(en)
|
2016-05-02 |
2017-11-09 |
Clearside Biomedical, Inc. |
Systems and methods for ocular drug delivery
|
|
US10501744B2
(en)
|
2016-05-04 |
2019-12-10 |
Indiana University Research And Technology Corporation |
Presentation of bioactive proteins
|
|
AU2017269839A1
(en)
|
2016-05-27 |
2018-11-22 |
Alexion Pharmaceuticals, Inc. |
Methods for treatment of refractory generalized myasthenia gravis
|
|
AU2017274654A1
(en)
|
2016-06-02 |
2018-12-20 |
Aquesys, Inc. |
Intraocular drug delivery
|
|
CA3027200A1
(en)
|
2016-06-13 |
2017-12-21 |
Massachusetts Institute Of Technology |
Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
|
|
CA3032822A1
(en)
|
2016-08-02 |
2018-02-08 |
Editas Medicine, Inc. |
Compositions and methods for treating cep290 associated disease
|
|
US10973681B2
(en)
|
2016-08-12 |
2021-04-13 |
Clearside Biomedical, Inc. |
Devices and methods for adjusting the insertion depth of a needle for medicament delivery
|
|
US11040019B2
(en)
|
2016-08-19 |
2021-06-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
|
EP3532616A1
(de)
|
2016-10-28 |
2019-09-04 |
Editas Medicine, Inc. |
Verfahren im zusammenhang mit crispr/cas und zusammensetzungen zur behandlung des herpes-simplex-virus
|
|
EP4520828A3
(de)
|
2016-11-15 |
2025-07-09 |
The Schepens Eye Research Institute, Inc. |
Zusammensetzungen und verfahren zur behandlung von aberranter angiogenese
|
|
JP2020518325A
(ja)
*
|
2016-12-29 |
2020-06-25 |
ピュア レイシオス ホールディングス， インコーポレイテッド |
モジュール式経皮送達システムならびに製造および使用の関連する方法
|
|
BR112019016827A2
(pt)
|
2017-02-17 |
2020-04-07 |
Trevena Inc |
compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
|
|
JP7185633B2
(ja)
|
2017-02-17 |
2022-12-07 |
トレベナ・インコーポレイテッド |
７員アザ複素環を含有するデルタ－オピオイド受容体調節化合物、その使用方法及び製造方法
|
|
EP3600345A4
(de)
|
2017-03-29 |
2021-01-06 |
Cornell University |
Oxidationsresistente aat-gentherapie
|
|
CN116059313A
(zh)
|
2017-04-07 |
2023-05-05 |
阿佩利斯制药有限公司 |
给药方案以及相关组合物和方法
|
|
US12090294B2
(en)
|
2017-05-02 |
2024-09-17 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
US11638724B2
(en)
|
2017-05-05 |
2023-05-02 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Ocular applications of matrix bound vesicles (MBVs)
|
|
EP3630042A4
(de)
*
|
2017-05-30 |
2021-06-23 |
Eximore Ltd. |
Zusammensetzungen und verfahren zur behandlung von trockenem auge mittels freisetzung von antibiotischem macrolid
|
|
KR20200019228A
(ko)
|
2017-06-21 |
2020-02-21 |
미토키닌, 인크. |
신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법
|
|
SG11202000105QA
(en)
|
2017-07-14 |
2020-02-27 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies and uses thereof
|
|
BR112020001703B1
(pt)
|
2017-07-27 |
2024-01-02 |
Alexion Pharmaceuticals, Inc |
Solução aquosa estável compreendendo um anticorpo anti-c5, método para produção desta solução, uso da mesma para tratar uma condição associada ao complemento e kit terapêutico compreendendo a mesma
|
|
WO2019033119A1
(en)
|
2017-08-11 |
2019-02-14 |
Unity Biotechnology, Inc. |
TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
KR20260011199A
(ko)
|
2017-10-02 |
2026-01-22 |
진에딧 인코포레이티드 |
변형된 cpf1 가이드 rna
|
|
WO2019070917A1
(en)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
|
|
CN111670033A
(zh)
|
2017-10-18 |
2020-09-15 |
华盛顿大学 |
作为神经变性疾病或病症的治疗策略的显性阴性sarm1分子
|
|
EP3700928A1
(de)
|
2017-10-26 |
2020-09-02 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5-antikörpern zur behandlung von paroxysmaler nächtlicher hämoglobinurie (pnh) und atypischem hämolytisch-urämischem syndrom (ahus)
|
|
WO2019090309A1
(en)
|
2017-11-06 |
2019-05-09 |
Massachusetts Institute Of Technology |
Anti-inflammatory coatings to improve biocompatibility of neurological implants
|
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
|
WO2019099560A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
KR20240167712A
(ko)
|
2017-12-15 |
2024-11-27 |
아펠리스 파마슈티컬스 인코포레이티드 |
투여 요법 및 관련 조성물 및 방법
|
|
US12226492B2
(en)
|
2017-12-29 |
2025-02-18 |
Cornell University |
Gene therapy for eosinophilic disorders
|
|
EP3743113B1
(de)
|
2018-01-23 |
2026-04-08 |
Mount Spec Investments Pty Ltd |
Expressionsvektor und verfahren
|
|
WO2019161378A1
(en)
|
2018-02-19 |
2019-08-22 |
University Of Miami |
Cyclophosphamide for treating ophthalmic inflammation
|
|
WO2019169291A1
(en)
|
2018-03-02 |
2019-09-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of il-34 to treat retinal inflammation and neurodegeneration
|
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
DE102018106217A1
(de)
|
2018-03-16 |
2019-09-19 |
Amw Gmbh |
Applikator
|
|
EP3775177A1
(de)
|
2018-04-03 |
2021-02-17 |
Cornell University |
Gentherapie für oxidativen stress
|
|
US11821009B2
(en)
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
|
US12404320B2
(en)
|
2018-05-31 |
2025-09-02 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients
|
|
JP7577542B2
(ja)
|
2018-06-04 |
2024-11-05 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
小児患者における非典型溶血性尿毒症症候群（ａＨＵＳ）の治療のための抗Ｃ５抗体の用量および投与
|
|
EP3814373A1
(de)
|
2018-06-28 |
2021-05-05 |
Alexion Pharmaceuticals, Inc. |
Verfahren zur herstellung von anti-c5 -antikörpern
|
|
CA3108324A1
(en)
|
2018-07-31 |
2020-02-06 |
Cornell University |
Gene therapy methods to control organ function
|
|
MX2021004994A
(es)
|
2018-10-30 |
2021-06-15 |
Alexion Pharma Inc |
Dosificacion subcutanea y administracion de anticuerpos anti-c5 para el tratamiento de la hemoglobinuria paroxistica nocturna (pnh).
|
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
US11793834B2
(en)
|
2018-12-12 |
2023-10-24 |
Kite Pharma, Inc. |
Chimeric antigen and T cell receptors and methods of use
|
|
WO2020176552A1
(en)
|
2019-02-25 |
2020-09-03 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
KR20220036946A
(ko)
|
2019-06-27 |
2022-03-23 |
레이어바이오 인크. |
안구 장치 전달 방법 및 시스템
|
|
WO2021022208A1
(en)
|
2019-08-01 |
2021-02-04 |
Kaplitt Michael G |
Targeted gene therapy to treat neurological diseases
|
|
WO2021062012A1
(en)
|
2019-09-25 |
2021-04-01 |
Emory University |
Use of klk10 and engineered derivatizations thereof
|
|
EP4038222A4
(de)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
Verfahren und zusammensetzungen zur identifizierung von neoantigenen zur verwendung bei der behandlung und vorbeugung von krebs
|
|
WO2021076794A1
(en)
|
2019-10-15 |
2021-04-22 |
Cornell University |
Methods for modulating level of expression from gene therapy expression cassette
|
|
US11471426B2
(en)
|
2019-10-16 |
2022-10-18 |
American River Nutrition, Llc |
Compositions comprising quinone and/or quinol and methods of preparations and use thereof
|
|
US20230405148A1
(en)
|
2019-10-16 |
2023-12-21 |
Cornell University |
Gene therapy for alzheimer's disease
|
|
WO2021086973A2
(en)
|
2019-10-28 |
2021-05-06 |
University Of Iowa Research Foundation |
Formulation for delivery of lubricin gene
|
|
IL293116A
(en)
|
2019-11-25 |
2022-07-01 |
Univ Cornell |
apoe gene therapy
|
|
WO2021230887A1
(en)
|
2020-05-15 |
2021-11-18 |
Eyeflow, Inc. |
Method and apparatus for implant in the conventional aqueous humor outflow pathway of a mammalian eye
|
|
EP4090381A1
(de)
|
2020-01-17 |
2022-11-23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
<smallcaps/>? ? crx-? ? ? ? ?gentherapie zur behandlung von autosomalen dominanten retinopathien
|
|
AU2021225926A1
(en)
|
2020-02-26 |
2022-10-20 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
EP4118202A1
(de)
|
2020-03-20 |
2023-01-18 |
Athanor Biosciences, Inc. |
Impfstoffe auf bakteriophagenbasis und manipulierter bakteriophagen
|
|
CA3179541A1
(en)
|
2020-04-05 |
2021-10-14 |
Athanor Biosciences, Inc. |
Bacteriophage-based antibodies and protein-based binders
|
|
CN115835886A
(zh)
|
2020-04-23 |
2023-03-21 |
衣阿华大学研究基金会 |
Gper蛋白水解靶向嵌合体
|
|
BR112022021450A2
(pt)
|
2020-04-24 |
2022-12-27 |
Millennium Pharm Inc |
O cd19 ou fragmento de ligação, método de tratamento de um câncer, composição farmacêutica, ácido nucleico, vetor, e, célula isolada
|
|
CN116194478A
(zh)
|
2020-06-24 |
2023-05-30 |
阿雷克森制药公司 |
皮下（sc）施用抗c5抗体治疗补体相关病症
|
|
CA3186586A1
(en)
|
2020-07-02 |
2022-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compound embodiments for treating retinal degeneration and method embodiments of making and using the same
|
|
US20230374483A1
(en)
|
2020-07-08 |
2023-11-23 |
Regents Of The University Of Minnesota |
Modified hexosaminidase and uses thereof
|
|
US20230295088A1
(en)
|
2020-08-12 |
2023-09-21 |
University Of Iowa Research Foundation |
Insulin sensitizers for the treatment of diabetes mellitus
|
|
WO2022040564A1
(en)
|
2020-08-21 |
2022-02-24 |
University Of Iowa Research Foundation |
Cationic nanoparticle adjuvants
|
|
US20230414787A1
(en)
|
2020-08-27 |
2023-12-28 |
University Of Iowa Research Foundation |
Gene knock-out for treatment of glaucoma
|
|
US20240100183A1
(en)
|
2020-12-11 |
2024-03-28 |
University Of Iowa Research Foundation |
Compositions comprising molecules for cystic fibrosis treatment
|
|
US12496612B2
(en)
|
2021-01-08 |
2025-12-16 |
Surmodics, Inc. |
Coating application system and methods for coating rotatable medical devices
|
|
EP4320149A1
(de)
|
2021-04-09 |
2024-02-14 |
Takeda Pharmaceutical Company Limited |
Gegen komplementfaktor d gerichtete antikörper und verwendungen davon
|
|
US20240207448A1
(en)
|
2021-04-16 |
2024-06-27 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
IL307939A
(en)
|
2021-04-26 |
2023-12-01 |
Millennium Pharm Inc |
Anti-CLEC12A antibodies and uses thereof
|
|
PE20242205A1
(es)
|
2021-04-26 |
2024-11-19 |
Millennium Pharm Inc |
Anticuerpos anti-adgre2 y usos de los mismos
|
|
WO2022246280A1
(en)
|
2021-05-21 |
2022-11-24 |
University Of Iowa Research Foundation |
Anti-oxidant containing particles and methods of use
|
|
US20240293322A1
(en)
|
2021-06-23 |
2024-09-05 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
|
MX2023015174A
(es)
|
2021-07-07 |
2024-01-23 |
Genentech Inc |
Sistema y metodos de insertador de varillas.
|
|
PE20242001A1
(es)
|
2021-10-20 |
2024-09-27 |
Takeda Pharmaceuticals Co |
Composiciones que actuan sobre bcma y metodos de uso de estas
|
|
US20250049758A1
(en)
|
2021-12-06 |
2025-02-13 |
Breye Therapeutics Aps |
Danegaptide Formulation for Application in the Eye
|
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2023164727A1
(en)
|
2022-02-28 |
2023-08-31 |
University Of Iowa Research Foundation |
A-fabp antibodies for diagnosis and treatment of obesity-associated diseases
|
|
WO2023215293A1
(en)
|
2022-05-02 |
2023-11-09 |
Athanor Biosciences, Inc. |
Cancer eradicating – bio-nanoparticles (ce-bnp)
|
|
WO2023215560A1
(en)
|
2022-05-05 |
2023-11-09 |
Atoosa Corporation |
Tumor cell/immune cell multivalent receptor engager – bio-nanoparticle (timre-bnp)
|
|
EP4680243A1
(de)
|
2023-03-17 |
2026-01-21 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Verfahren zur behandlung von altersbedingter makuladegeneration
|
|
WO2024233783A1
(en)
|
2023-05-09 |
2024-11-14 |
Cornell University |
Expression cassette coding for vascular endothelial growth factor
|
|
CN119265241A
(zh)
|
2023-06-30 |
2025-01-07 |
深圳菁童生命科学有限公司 |
一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法
|
|
WO2025038668A1
(en)
|
2023-08-14 |
2025-02-20 |
Voro Therapeutics, Inc. |
Therapeutic binding agents that conditionally promote myeloid cell activity against target cells and uses thereof
|
|
WO2025083169A1
(en)
|
2023-10-17 |
2025-04-24 |
Tenpoint Therapeutics Limited |
Combination of a vegf inhibitor and a complement pathway inhibitor for treating ocular disorders
|
|
WO2025171234A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to muscle tissue
|
|
WO2025171280A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to adipose tissue
|
|
WO2025213111A2
(en)
|
2024-04-05 |
2025-10-09 |
Cornell University |
Aav expression of mirna to suppress human apoe mrna
|
|
WO2025213138A1
(en)
|
2024-04-05 |
2025-10-09 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma
|